DUBLIN and CHICAGO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a company focused on delivering next generation oral and IV antibiotics to treat infections ...
No significant differences in resistance were observed against participants with acne vulgaris (AV) against 7 antibiotics. Moreover, some resistances were seen against clindamycin, erythromycin, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results